🔗 Permalink

Inventor profile of:

Umesh Muchhal

City:

Monrovia, California

Country:

United States

Published Applications:

Last publication date:

2025-10-02

Top Assignees for applications by Umesh Muchhal

The entities that hold a legal rights for patent applications filed by inventor Muchhal Umesh:

XENCOR, INC. 13 Monrovia, CA United States
Xencor, Inc. 5 Pasadena, CA United States
Allergan, Inc. 3 Irvine, CA United States
Xencor, Inc. 1 Pasasdena, CA United States
Xencor 1 Monrovia, CA United States

Recent patent applications by Muchhal Umesh

Umesh Muchhal from Monrovia, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-02

US20250304724A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

#2 | 2025-10-02

US20250304667A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C5 ANTIBODIES

#3 | 2025-04-03

US20250109215A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

#4 | 2025-04-03

US20250109214A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

#5 | 2024-08-22

US20240279317A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C5 ANTIBODIES

#6 | 2023-11-16

US20230365717A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

#7 | 2022-12-22

US20220403049A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and CD38

#8 | 2022-06-30

US20220204624A1

Chemistry; metallurgy

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

#9 | 2022-05-26

US20220162343A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#10 | 2022-02-10

US20220041757A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#11 | 2021-04-08

US20210102003A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#12 | 2021-04-08

US20210101965A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C5 ANTIBODIES

#13 | 2020-06-25

US20200199251A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and CD38

#14 | 2019-08-29

US20190263909A1

Chemistry; metallurgy

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

#15 | 2019-07-04

US20190202938A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#16 | 2018-10-25

US20180305465A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

#17 | 2018-10-04

US20180282432A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#18 | 2018-08-09

US20180223000A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#19 | 2018-08-09

US20180222969A1

Chemistry; metallurgy

Complement component C5 antibodies

#20 | 2017-10-26

US20170306007A1

Chemistry; metallurgy

Nucleic acids encoding complement component C5 antibodies

#21 | 2017-03-23

US20170081424A1

Chemistry; metallurgy

Heterodimeric antibodies to CD3 X CD123

#22 | 2017-03-23

US20170081420A1

Chemistry; metallurgy

Heterodimeric antibodies to CD3 X CD20

#23 | 2016-12-08

US20160355608A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#24 | 2016-08-11

US20160229924A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and tumor antigens

#25 | 2016-07-28

US20160215063A1

Chemistry; metallurgy

Heterodimeric antibodies that bind CD3 and CD38

#26 | 2015-08-27

US20150239966A1

Chemistry; metallurgy

Complement component C5 antibodies

#27 | 2007-09-06

US20070207961A1

Human necessities

TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS

#28 | 2005-03-10

US20050054053A1

Chemistry; metallurgy

Interferon variants with improved properties

InventorID:

1269323 ⎘